https://www.selleckchem.com/pr....oducts/Cyclopamine.h
urrence of hypoglycemia. Estimating glycemic variability (GV) through within-day coefficient of variation (%CV ) is recommended for patients with type 1 Diabetes (T1D). High GV (hGV) is defined as %CV 36%. However, continuous glucose monitoring (CGM) devices provide exclusively total CV (%CV ). We aimed to assess consequences of this disparity. We retrospectively calculated both %CV and %CV of consecutive T1D patients from their CGM raw data during 14 days. Patients with hGV with %CV 36% and %CV ≤36% were called the "incons